Lotus Eye Hospital and Institute Limited (BOM:532998)
India · Delayed Price · Currency is INR 121.35
-0.70 (-0.57%)
At close: Jun 10, 2026
BOM:532998 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 537.14 | 495.63 | 482.1 | 470.44 | 389.1 | |
Revenue Growth (YoY) | 8.38% | 2.81% | 2.48% | 20.91% | 20.24% |
Cost of Revenue | 397.4 | 389.33 | 346.44 | 326.07 | 273.31 |
Gross Profit | 139.74 | 106.3 | 135.66 | 144.37 | 115.79 |
Selling, General & Admin | - | 33.14 | 34.58 | 34 | 31.53 |
Other Operating Expenses | 105.91 | 34.43 | 31.39 | 30.25 | 22.81 |
Operating Expenses | 143.4 | 97.64 | 103.24 | 94.05 | 79.36 |
Operating Income | -3.67 | 8.66 | 32.42 | 50.32 | 36.43 |
Interest Expense | -8.59 | -3.55 | -0.97 | -0.98 | -1.28 |
Interest & Investment Income | - | 3.58 | 4.98 | 4.67 | 4.32 |
Other Non Operating Income (Expenses) | 11.76 | 5.04 | 3.66 | 2.52 | 1.56 |
EBT Excluding Unusual Items | -0.5 | 13.73 | 40.08 | 56.54 | 41.04 |
Other Unusual Items | -0.04 | 0.1 | 0.06 | -0.02 | -0.1 |
Pretax Income | -0.54 | 13.83 | 40.14 | 56.52 | 40.94 |
Income Tax Expense | -1.34 | 6.43 | 10.99 | 15.75 | 11.09 |
Net Income | 0.8 | 7.39 | 29.15 | 40.78 | 29.85 |
Net Income to Common | 0.8 | 7.39 | 29.15 | 40.78 | 29.85 |
Net Income Growth | -89.13% | -74.63% | -28.52% | 36.62% | 90.34% |
Shares Outstanding (Basic) | 20 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 20 | 21 | 21 | 21 | 21 |
Shares Change (YoY) | -2.12% | -1.35% | 0.07% | 0.38% | -0.34% |
EPS (Basic) | 0.04 | 0.36 | 1.40 | 1.96 | 1.44 |
EPS (Diluted) | 0.04 | 0.36 | 1.40 | 1.96 | 1.44 |
EPS Growth | -88.89% | -74.29% | -28.57% | 36.11% | 90.98% |
Free Cash Flow | -100.27 | -21.28 | 0.4 | 12.9 | -2.73 |
Free Cash Flow Per Share | -4.99 | -1.04 | 0.02 | 0.62 | -0.13 |
Dividend Per Share | - | - | - | 0.500 | 0.500 |
Gross Margin | 26.02% | 21.45% | 28.14% | 30.69% | 29.76% |
Operating Margin | -0.68% | 1.75% | 6.73% | 10.70% | 9.36% |
Profit Margin | 0.15% | 1.49% | 6.04% | 8.67% | 7.67% |
Free Cash Flow Margin | -18.67% | -4.29% | 0.08% | 2.74% | -0.70% |
EBITDA | 33.83 | 28.01 | 63.37 | 74.74 | 55.73 |
EBITDA Margin | 6.30% | 5.65% | 13.14% | 15.89% | 14.32% |
D&A For EBITDA | 37.49 | 19.35 | 30.95 | 24.42 | 19.3 |
EBIT | -3.67 | 8.66 | 32.42 | 50.32 | 36.43 |
EBIT Margin | -0.68% | 1.75% | 6.73% | 10.70% | 9.36% |
Effective Tax Rate | - | 46.53% | 27.39% | 27.86% | 27.09% |
Revenue as Reported | 548.9 | 508.64 | 495.13 | 481.89 | 397.96 |